Literature DB >> 21165575

ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.

Seiji Sakata1, Masachika Fujiwara, Kouki Ohtsuka, Hiroshi Kamma, Motoo Nagane, Atsuhiko Sakamoto, Yasunori Fujioka.   

Abstract

Most tumors in the central nervous system are drug resistant partly because of the presence of the blood-brain barrier (BBB) between circulating blood and tumor tissues. Primary central nervous system lymphoma (PCNSL) is one of the exceptions, as it is highly sensitive to high-dose methotrexate (MTX)-based chemotherapy. The aim of this study was to evaluate the BBB function of tumor capillary endothelial cells in PCNSL. Expression of three major drug efflux transporters that belong to the ATP-binding cassette (ABC) superfamily, P-glycoprotein encoded by the human multidrug resistance gene (MDR1 Pgp; ABCB1), breast cancer resistance protein (BCRP; ABCG2), and multidrug resistance-associated protein 1 (MRP1; ABCC1), was evaluated. Immunohistochemistry was performed in capillary endothelial cells of 30 tumor areas from 22 PCNSL cases and compared with that of 30 gliomas. The microenvironment around tumor capillaries was assessed by examining the distribution of astrocytes and by counting the number of macrophages and T-cells, the principal cytokine producers. In PCNSL, expression of MDR1 Pgp and BCRP in tumor capillary endothelial cells was decreased in 63 and 93% of tumor areas examined, respectively, and these reduction levels differed significantly from those of gliomas (P<0.05). When the PCNSLs were further segregated by way of infiltration of tumor cells into three patterns (dense, perivascular and sparse), decreased MDR1 Pgp and BCRP in tumor capillary endothelial cells were much more prominent in dense and perivascular patterns. In all tumors and non-tumor areas of the brain, MRP1 was undetected on capillary endothelial cells. Assessment of the microenvironment around the tumor capillaries suggested that dissociation from astrocytes and infiltration of macrophages and T-cells was involved in the down-regulation of MDR1 Pgp and BCRP in capillary endothelial cells. In conclusion, we report that expression of the major ABC transporters of the BBB, MDR1 Pgp and BCRP, decreases in tumor capillary endothelial cells of PCNSL. Thus, decreased expression may permit delivery of chemotherapeutic agents to the tumor tissues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21165575     DOI: 10.3892/or.2010.1102

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

Review 1.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

Review 2.  Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.

Authors:  Sagar Agarwal; Anika M S Hartz; William F Elmquist; Björn Bauer
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats.

Authors:  Ping Xu; Zhao-Li Ling; Ji Zhang; Ying Li; Nan Shu; Ze-Yu Zhong; Yang Chen; Xin-Yu Di; Zhong-Jian Wang; Li Liu; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

4.  Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.

Authors:  Ngoc H On; Ryan Mitchell; Sanjot D Savant; Corbin J Bachmeier; Grant M Hatch; Donald W Miller
Journal:  J Neurooncol       Date:  2012-11-27       Impact factor: 4.130

5.  Ubc9 expression predicts chemoresistance in breast cancer.

Authors:  Shi-Feng Chen; Chang Gong; Ming Luo; He-Rui Yao; Yun-Jie Zeng; Feng-Xi Su
Journal:  Chin J Cancer       Date:  2011-09

Review 6.  A Comprehensive Review of Cross-Linked Gels as Vehicles for Drug Delivery to Treat Central Nervous System Disorders.

Authors:  Leshasha T Mashabela; Mahlako M Maboa; Ntombi F Miya; Taiwo O Ajayi; Rumbidzai S Chasara; Marnus Milne; Shoeshoe Mokhele; Patrick H Demana; Bwalya A Witika; Xavier Siwe-Noundou; Madan S Poka
Journal:  Gels       Date:  2022-09-06

7.  Establishment of recombinant lentiviral vector with ABCG2 overexpression and effects of the recombinant on human breast cancer MCF-7 cells' biological characteristics.

Authors:  Yuanming Fan; Chengyi Wu
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-11

8.  Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells.

Authors:  Xiao-Hong Xie; Hong Zhao; Yuan-Yuan Hu; Xi-Dong Gu
Journal:  Exp Ther Med       Date:  2014-08-26       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.